Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Effect of enzyme replacement therapy on lipid profile in patients with Gaucher's disease].

Medicina clinica - 10 May 2003

Alfonso Pilar, Cenarro Ana, Pérez-Calvo Juan Ignacio, Puzo José, Giralt Manuel, Giraldo Pilar, Pocoví Miguel

Abstract excerpt

BACKGROUND AND OBJECTIVE: Gaucher's disease (GD) is a lysosomal storage disorder, caused by a deficiency of the acid -glucocerebrosidase enzyme, which results in accumulation of lipids within macrophages. GD patients show decreased plasma total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c) and high-density lipoprotein cholesterol (HDL-c) levels, as well as decreased apolipoprotein (apo) A-I and B....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein A-I
Share to Apolipoproteins B

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholesterol, HDL

Share to Gaucher Disease

Share to Glucosylceramidase

Share to Hexosaminidases

Share to Lipids

Share to Treatment Outcome

Source

Identifiers

PMID: 12747811
DOI: 10.1016/s0025-7753(03)73797-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Effect of enzyme replacement therapy on lipid profile in patients with Gaucher's disease].PMID 12747811Read ↗

Plasma chitotriosidase activity versus plasma glucosylsphingosine in wide spectrum of Gaucher disease phenotypes - A statistical insight.Semantic proximity Read ↗

Gaucher Disease: Clinical, Biological and Therapeutic AspectsSemantic proximity Read ↗

[Pathogenic mechanism and therapies for Gaucher's disease].Semantic proximity Read ↗

Glucosylsphingosine Is a Highly Sensitive and Specific Biomarker for Primary Diagnostic and Follow-Up Monitoring in Gaucher Disease in a Non-Jewish, Caucasian Cohort of Gaucher Disease PatientsSemantic proximity Read ↗

Blood oxidative stress markers in Gaucher disease patients.Semantic proximity Read ↗

[Therapeutic objectives in Gaucher disease].Semantic proximity Read ↗

Chitotriosidase genotype and plasma activity in patients type 1 Gaucher's disease and their relatives (carriers and non carriers).Semantic proximity Read ↗

[Enzyme replacement therapy for Gaucher disease introduced in late adulthood].Semantic proximity Read ↗

Enzyme replacement therapy for Gaucher diseaseSemantic proximity Read ↗

Plasma glucosylceramide and ceramide in type 1 Gaucher disease patients: correlations with disease severity and response to therapeutic intervention.Semantic proximity Read ↗

Cholelithiasis in Patients with Gaucher Disease type 1: Risk Factors and the Role of ABCG5/ABCG8 Gene Variants.Semantic proximity Read ↗

The metabolism of glucocerebrosides - From 1965 to the present.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.